Improved antitumor effect of the nitrosourea drugs tauromustine (TCNU) and carmustine (BCNU) on a rat liver adenocarcinoma after hepatic arterial administration with degradable starch microspheres.

Abstract

The effect of the cytostatic nitrosourea drugs TCNU and BCNU on tumor growth was studied in rats with a transplantable colon adenocarcinoma implanted into the liver. The drugs were given as a single dose into the hepatic artery alone or together with degradable starch microspheres (DSM). The effect of the treatment on tumor growth was measured 7 days later. Compared to control animals, TCNU decreased tumor growth. BCNU alone did not significantly decrease tumor growth. The antitumor effect of both drugs was significantly improved by DSM. The addition of DSM to the drugs caused liver damage in a few rats. There were no differences between different treatment groups regarding body weight changes. DSM may protect bone marrow against BCNU toxicity. Injection of DSM alone had no effect either on tumor growth or on survival.

• Authors: G Roos, I A el Hag, H Teder, U Stenram
• Journal: Anticancer research (Anticancer Res) 1991 Jan-Feb Vol. 11 Issue 1 Pg. 13-6 ISSN: 0250-7005 [Print] Greece
• PMID: 2018346 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Antineoplastic Agents
• Drug Carriers
• Nitrosourea Compounds
• Taurine
• 1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea
• Starch
• Carmustine

Topics

• Adenocarcinoma (drug therapy)
• Animals
• Antineoplastic Agents (administration & dosage)
• Carmustine (administration & dosage, therapeutic use)
• Drug Carriers
• Hepatic Artery
• Injections, Intra-Arterial
• Liver Neoplasms (drug therapy)
• Male
• Microspheres
• Nitrosourea Compounds (administration & dosage, therapeutic use)
• Rats
• Rats, Inbred Strains
• Starch
• Taurine (administration & dosage, analogs & derivatives, therapeutic use)